bioRxivPharmacology & Toxicology
In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases
Abstract
Potent, selective, and cell active small molecule kinase inhibitors are useful tools to help unravel the complexities of kinase signaling. As the biological functions of individual kinases become better understood, they can become targets of drug discovery efforts. The small molecules used to shed light on function can also then serve as chemical starting points in these drug discovery efforts. The Nek family of kinases has received very little attention, as judged by number of citations in PubMed, yet they appear to play many key roles and have been implicated in disease. Here we present our work to identify high quality chemical starting points that have emerged due to the increased incidence of broad kinome screening. We anticipate that this analysis will allow the community to progress towards the generation of chemical probes and eventually drugs that target members of the Nek family.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases
Andrea I. Krahn, Carrow I. Wells, … Alison Donnelly Axtman·ACS Chemical NeurosciencePeer-reviewed·May 28, 2020
- Progress Towards a Public Chemogenomic Set for Protein Kinases and a Call for Contributions
D. H. Drewry, C. I. Wells, … T. M. Willson·bioRxiv·Jan 31, 2017
- Computational and Structure-Guided E-Pharmacophore-Based Virtual Screening for the Identification of Novel NEK2 Kinase Inhibitors as Potential Anticancer Agents
Hafiz Muzzammel Rehman, Ayesha Latif, … Muhammad Sajjad·bioRxiv·Aug 6, 2026
- Exploring the understudied human kinome for research and therapeutic opportunities
Nienke Moret, Changchang Liu, … Peter Karl Sorger·bioRxiv·Apr 2, 2020
- The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification
C. I. Wells, H. Al-Ali, … D. H. Drewry·bioRxiv·Dec 22, 2019
- Polypharmacology is an enduring and nearly universal property of kinase inhibitors
Caitlin E. Mills, Clemens B. Hug, … Peter Karl Sorger·bioRxiv·Apr 30, 2026